Disease management
The company was also the first to receive emergency use authorization for its home COVID-19 test in 2021.
It is currently conducting an in-human trial of its diagnostic patch.
The partners will develop a database for academics and biopharma researchers to acquire insights to help advance cancer-focused research.
Sigurjon Kristjansson, CEO of Nox Health, tells MobiHealthNews why his company made the largest bid for Pear Therapeutics' assets at a recent bankruptcy auction
The company will use the funds to support and grow its team, enhance its platform and expand partnerships with payors, health systems and physicians.
The Utah-based company will utilize Microsoft's AI technology to expand its machine learning speech models and accelerate AI-enabled speech analysis technology.
The company's iPredict System allows providers to detect age-related macular degeneration in the clinical setting.
MJFF will use H1's AI-enabled platform to evaluate treatment approaches and improve clinical trial access for patients with Parkinson's from marginalized communities.
It can potentially help doctors prevent or better manage kidney disease in patients with Type 2 diabetes.
Also, HeraMED is deploying its remote pregnancy monitoring solutions in a private practice in Perth.